中国全科医学2017，Vol.20Issue(29)：3579-3583,5.DOI:10.3969/j.issn.1007-9572.2017.00.060
2017 ACC/AHA/HFSA心力衰竭管理指南更新解读
Interpretation of 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
许顶立 1白煜佳1
作者信息
- 1. 510515 广东省广州市,南方医科大学南方医院心血管内科
- 折叠
摘要
Abstract
The ACC,AHA and Heart Failure Society of America (HFSA) updated the 2013 ACCF/AHA Guideline for the Management of Heart Failure in 2017.The focused update involved the revision of the sections on biomarkers,new therapies including ARNI and Ivabradine demonstrated for stage C heart failure (HF) with reduced ejection fraction (HFrEF) and so on.关键词
心力衰竭/病例管理/指南Key words
Heart failure/Case management/Guideline分类
医药卫生引用本文复制引用
许顶立,白煜佳..2017 ACC/AHA/HFSA心力衰竭管理指南更新解读[J].中国全科医学,2017,20(29):3579-3583,5.
